6EHV

scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery

• PDB DOI: https://doi.org/10.2210/pdb6EHV/pdb

• Classification: IMMUNE SYSTEM
• Organism(s): Homo sapiens
• Expression System: Escherichia coli 'BL21-Gold(DE3)pLysS AG
• Mutation(s): No 


• Deposited: 2017-09-15 Released: 2017-11-08 
• Deposition Author(s): Hargreaves, D.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.54 Å
• R-Value Free: 0.314 
• R-Value Work: 0.275 
• R-Value Observed: 0.276 

Literature

scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery

Hargreaves, D.

To be published.

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 generated by PISA (software)

Biological Assembly Evidence: gel filtration

Macromolecule Content

• Total Structure Weight: 27.49 kDa 
• Atom Count: 1,848 
• Modelled Residue Count: 227 
• Deposited Residue Count: 254 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery	A [auth X]	254	Homo sapiens	Mutation(s): 0

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.54 Å
• R-Value Free: 0.314 
• R-Value Work: 0.275 
• R-Value Observed: 0.276 
• Space Group: I 4₁ 2 2

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 132.899	α = 90
b = 132.899	β = 90
c = 80.746	γ = 90

Software Package:

Software Name	Purpose
BUSTER	refinement
XDS	data reduction
XDS	data scaling
PHASER	phasing

Structure Validation

Entry History 

Deposition Data

• Released Date: 2017-11-08 
Deposition Author(s): Hargreaves, D.

Revision History  

• Version 1.0: 2017-11-08
  Type: Initial release
  
• Version 1.1: 2019-10-16
  Changes: Data collection